PFIZER INC.
๐บ๐ธUnited States
- Country
- ๐บ๐ธUnited States
- Ownership
- Public
- Established
- 1849-01-01
- Employees
- 88K
- Market Cap
- $163.3B
- Website
- http://www.pfizer.com
Vaginal Heat Wash-out (HWO) in 4 Groups of Women (Pre- and Postmenopausal With and Without Female Sexual Arousal Disorder (FSAD)).
Phase 1
Completed
- Conditions
- Sexual Dysfunction, Physiological
- Interventions
- Device: Vaginal Heat Wash-Out Device
- First Posted Date
- 2007-03-05
- Last Posted Date
- 2019-05-28
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 64
- Registration Number
- NCT00443248
- Locations
- ๐ฆ๐บ
Pfizer Investigational Site, Nedlands, Western Australia, Australia
Effect Of Menstrual Cycle On Vaginal Blood Flow In Pre-Menopausal Healthy Women.
Phase 1
Completed
- Conditions
- Sexual Dysfunction, Physiological
- Interventions
- Device: Vaginal Heat Wash-Out Device
- First Posted Date
- 2007-03-05
- Last Posted Date
- 2019-05-28
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 12
- Registration Number
- NCT00443027
- Locations
- ๐ฆ๐บ
Pfizer Investigational Site, Nedlands, Western Australia, Australia
A Clinical Trial Comparing The Efficacy And Safety Of 2 Different Initial Dose Prescriptions For Exubera.
Phase 4
Terminated
- Conditions
- Diabetes Mellitus, Type 2
- Interventions
- Drug: Inhaled Human Insulin (Exubera)
- First Posted Date
- 2007-02-21
- Last Posted Date
- 2009-05-11
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 49
- Registration Number
- NCT00437489
- Locations
- ๐ธ๐ฌ
Pfizer Investigational Site, Singapore, Singapore
PF-00477736 Is Being Studied In Advanced Solid Tumors In Combination With Chemotherapy With Gemcitabine
- First Posted Date
- 2007-02-19
- Last Posted Date
- 2012-04-03
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 43
- Registration Number
- NCT00437203
- Locations
- ๐ฆ๐บ
Pfizer Investigational Site, East Melbourne, Victoria, Australia
A Study Of Sunitinib In Combination With Capecitabine Compared With Capecitabine In Patients With Breast Cancer
Phase 3
Completed
- Conditions
- Breast Neoplasms
- Interventions
- First Posted Date
- 2007-02-15
- Last Posted Date
- 2012-06-26
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 442
- Registration Number
- NCT00435409
- Locations
- ๐ฌ๐ง
Pfizer Investigational Site, Worthing, United Kingdom
Efficacy And Safety Of Parecoxib IV/IM 40 Mg Vs Placebo Following Sub Muscular Breast Augmentation
Phase 4
Withdrawn
- Conditions
- Pain, Postoperative
- First Posted Date
- 2007-02-15
- Last Posted Date
- 2012-03-14
- Lead Sponsor
- Pfizer
- Registration Number
- NCT00435747
Dalteparin Versus Unfractionated Heparin In Patients With Acute Coronary Syndrome
Phase 4
Terminated
- Conditions
- Angina, UnstableMyocardial Infarction
- Interventions
- First Posted Date
- 2007-02-15
- Last Posted Date
- 2011-10-17
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 173
- Registration Number
- NCT00435487
- Locations
- ๐ฎ๐ณ
Pfizer Investigational Site, Karnataka, India
Treatment Of Adult Growth Hormone Deficiency After Traumatic Brain Injury.
Phase 4
Withdrawn
- Conditions
- Brain Injuries
- First Posted Date
- 2007-02-07
- Last Posted Date
- 2015-04-22
- Lead Sponsor
- Pfizer
- Registration Number
- NCT00432263
Safety And Efficacy Of UK-432,097 In Chronic Obstructive Pulmonary Disease.
Phase 2
Terminated
- Conditions
- Pulmonary Disease, Chronic Obstructive
- Interventions
- Drug: UK-432,097Drug: Placebo
- First Posted Date
- 2007-02-01
- Last Posted Date
- 2013-07-08
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 87
- Registration Number
- NCT00430300
- Locations
- ๐ฌ๐ง
Pfizer Investigational Site, Southampton, United Kingdom
A Study Of Sunitinib Compared To Placebo For Patients With Advanced Pancreatic Islet Cell Tumors
Phase 3
Terminated
- Conditions
- Carcinoma, Islet CellCarcinoma, Pancreas
- Interventions
- Drug: PlaceboDrug: sunitinib malate
- First Posted Date
- 2007-01-30
- Last Posted Date
- 2010-10-11
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 171
- Registration Number
- NCT00428597
- Locations
- ๐ฌ๐ง
Pfizer Investigational Site, Manchester, United Kingdom
ยฉ Copyright 2025. All Rights Reserved by MedPath